Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 12310
TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM50629206(CHEMBL5419793)
Affinity DataIC50: 1.30nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694614(US20240294509, Compound 24)
Affinity DataIC50: 2.10nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694608(US20240294509, Compound 18)
Affinity DataIC50: 2.20nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694608(US20240294509, Compound 18)
Affinity DataIC50: 2.5nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM50629206(CHEMBL5419793)
Affinity DataIC50: 2.90nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694636(US20240294509, Compound 63)
Affinity DataIC50: 3nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694613(US20240294509, Compound 23)
Affinity DataIC50: 3.20nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694610(US20240294509, Compound 20)
Affinity DataIC50: 3.20nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694621(US20240294509, Compound 34)
Affinity DataIC50: 3.30nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694611(US20240294509, Compound 21)
Affinity DataIC50: 3.40nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694623(US20240294509, Compound 36)
Affinity DataIC50: 3.80nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694628(US20240294509, Compound 41)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694637(US20240294509, Compound 66)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694628(US20240294509, Compound 41)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694627(US20240294509, Compound 40)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694630(US20240294509, Compound 43)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694606(US20240294509, Compound 1)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694630(US20240294509, Compound 43)
Affinity DataIC50: 4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694614(US20240294509, Compound 24)
Affinity DataIC50: 4.10nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694622(US20240294509, Compound 35)
Affinity DataIC50: 4.30nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694618(US20240294509, Compound 31)
Affinity DataIC50: 4.40nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694609(US20240294509, Compound 19)
Affinity DataIC50: 4.40nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694615(US20240294509, Compound 27)
Affinity DataIC50: 4.40nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694612(CHEMBL5407196 | US20240294509, Compound 22)
Affinity DataIC50: 4.60nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM431646(5-[[(2S)-1-(3-Oxo-3-[4-[5-(trifluoromethyl)pyrimid...)
Affinity DataIC50: 4.60nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694625(US20240294509, Compound 38)
Affinity DataIC50: 5nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694617(US20240294509, Compound 30)
Affinity DataIC50: 5.10nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694629(US20240294509, Compound 42)
Affinity DataIC50: 6nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694627(US20240294509, Compound 40)
Affinity DataIC50: 7nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694624(US20240294509, Compound 37)
Affinity DataIC50: 7nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694631(US20240294509, Compound 44)
Affinity DataIC50: 7nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694617(US20240294509, Compound 30)
Affinity DataIC50: 7.60nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694626(US20240294509, Compound 39)
Affinity DataIC50: 8nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694613(US20240294509, Compound 23)
Affinity DataIC50: 9.70nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694619(US20240294509, Compound 32)
Affinity DataIC50: 10.1nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694615(US20240294509, Compound 27)
Affinity DataIC50: 12.5nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694633(US20240294509, Compound 50)
Affinity DataIC50: 13nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694621(US20240294509, Compound 34)
Affinity DataIC50: 13.6nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694623(US20240294509, Compound 36)
Affinity DataIC50: 14.4nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694619(US20240294509, Compound 32)
Affinity DataIC50: 14.6nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694633(US20240294509, Compound 50)
Affinity DataIC50: 15nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694631(US20240294509, Compound 44)
Affinity DataIC50: 18nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694616(US20240294509, Compound 29)
Affinity DataIC50: 18.3nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694620(US20240294509, Compound 33)
Affinity DataIC50: 22.2nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694616(US20240294509, Compound 29)
Affinity DataIC50: 25.6nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694618(US20240294509, Compound 31)
Affinity DataIC50: 25.9nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694632(US20240294509, Compound 49)
Affinity DataIC50: 26nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694612(CHEMBL5407196 | US20240294509, Compound 22)
Affinity DataIC50: 31.6nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694625(US20240294509, Compound 38)
Affinity DataIC50: 36nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetProtein mono-ADP-ribosyltransferase TIPARP(Human)
Euregen Biopharma Co.

US Patent
LigandPNGBDBM694629(US20240294509, Compound 42)
Affinity DataIC50: 37nMAssay Description:(1) Pre-coating: Add 100 μL of a PBS buffer (10 mM NaH2PO4, 10 mM Na2HPO4, 150 mM NaCl, pH 7.4) containing 20 g/mL of histone to each well of a ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: